Skip to main content
  • WHO Moves to Establish Global Standards for Herbal Medicines Through International Pharmacopoeia Initiative

    The World Health Organization (WHO) has taken another significant step toward strengthening the quality, safety, and regulation of herbal medicines by advancing the development of an International Herbal Pharmacopoeia (IHP). During the 5th WHO Expert Meeting held in Hong Kong SAR (China) from 16–18 June 2026, experts from all six WHO regions met to accelerate the creation of globally harmonized standards for herbal medicines.

  • Novartis malaria treatment Coartem® Baby receives WHO prequalification
    Novartis announced that the World Health Organization (WHO) has prequalified Coartem® (artemether-lumefantrine) Baby, the first and only antimalarial developed specifically for newborns and young infants weighing from 2 to 5 kilograms.
  • World Health Organization looking for Public Health Professionals
    Junior Public Health Professional Programme in WHO South-East Asia Region has been operational since 2011. The programme aims to provide young public health professionals (under 35 years of age) from SEAR Member States with a valuable opportunity for hands-on learning and leadership development within the WHO environment
  • Work as HSO - Data Systems and Digitalization at WHO India
    University degree in health sciences or public health. WHO India Country Office collaborates with the Government of India and relevant stakeholders within the framework of the collaborative Country Cooperation Strategy (CCS), to actively support the development and implementation of national health policies
  • Career for M.Pharm as Consultant at World Health Organization
    To contribute to the development of AMR curriculum assessment tools for pharmacy and nursing education; and to support youth engagement and AMR awareness-raising activities.
  • WHO adds an HPV vaccine for single-dose use
    WHO announced that a fourth WHO-prequalified human papillomavirus vaccine product, Cecolin has been confirmed for use in a single-dose schedule. The decision is made based on new data on the product that fulfilled the criteria set out in the WHO 2022 recommendations for alternative, off-label use of HPV vaccines in single-dose schedules.
  • WHO Director-General declares mpox outbreak a public health emergency of international concern
    WHO Director-General Dr Tedros Adhanom Ghebreyesus has determined that the upsurge of mpox in the Democratic Republic of the Congo and a growing number of countries in Africa constitutes a public health emergency of international concern under the International Health Regulations.
  • WHO prequalifies new dengue vaccine
    WHO recommends the use of TAK-003 in children aged 6–16 years in settings with high dengue burden and transmission intensity. The vaccine should be administered in a 2-dose schedule with a 3-month interval between doses.
  • WHO launches new manual to support delivery of psychological interventions

    By providing practical guidance on how to implement psychological interventions, this guide will help increase access to evidence-based interventions so that more people can benefit from them. The manual focuses on evidence-based psychological intervention manuals delivered by a non-specialist workforce.

  • WHO lanuches ICD-11, Traditional Medicine Module 2

    With the launch of ICD 11, Traditional Medicine Module 2 by the World Health Organization today, preparations have started for its implementation. The data and terminology relating to diseases based on Ayurveda, Siddha and Unani Medicine have been included in the WHO ICD-11 classification. With this effort, the terminology defining diseases in Ayurveda, Unani and Siddha medicine has been indexed as a code and included in the WHO Disease Classification Series ICD-11.

Subscribe to WHO